Advagene Biopharma Co., Ltd.
6709
Rank in Stocks
#23029
Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to... Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to pioneering advancements in vaccine science and associated medical solutions. Its current development portfolio comprises a nasal spray vaccine for influenza, various allergy-specific vaccines, and an immunotherapy targeting COVID-19.
Share Price
$0.67370654
Last synced: 2026-11-10
Market Cap
$46.74M
Change (1 day)
2.31%
Change (1 year)
-35.05%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Advagene Biopharma Co., Ltd. (6709)
Category
Healthcare
EPS for Advagene Biopharma Co., Ltd. (6709)
EPS as of June 2026 TTM: $-0.05
According to Advagene Biopharma Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.05. At the end of 2025 the company had an EPS of $-0.04, equal to its 2024 EPS of $-0.04.
EPS history for Advagene Biopharma Co., Ltd. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.05 | 16.50% |
| 2025 | $-0.04 | -5.43% |
| 2024 | $-0.04 | -35.07% |
| 2023 | $-0.06 | -23.88% |
| 2022 | $-0.08 | 15.49% |
| 2021 | $-0.07 | 21.29% |
| 2020 | $-0.06 | -18.39% |
| 2019 | $-0.07 | -15.22% |
| 2018 | $-0.08 | -49.75% |
| 2017 | $-0.16 | 28.13% |
| 2016 | $-0.13 | 13.47% |
| 2015 | $-0.11 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -33,705.15% |
US
|
|
| $-7.07 | 15,071.67% |
US
|
|
| $-5.29 | 11,251.93% |
AU
|
|
| $12.88 | -27,739.70% |
BE
|
|
| $21.56 | -46,366.09% |
NL
|
Questions about Advagene Biopharma Co., Ltd.'s earnings per share (EPS)
What is Advagene Biopharma Co., Ltd.'s earnings per share (EPS)?
Advagene Biopharma Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.05, as of Jun 2026.
What was Advagene Biopharma Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Advagene Biopharma Co., Ltd.'s earnings per share (EPS) was $-0.04, compared with $-0.04 in 2024.
How has Advagene Biopharma Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Advagene Biopharma Co., Ltd.'s earnings per share (EPS) was highest in 2025 ($-0.04) and lowest in 2022 ($-0.08).
How does Advagene Biopharma Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Advagene Biopharma Co., Ltd.'s earnings per share (EPS) ($-0.05) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.